Considerable variability has been observed in the steady-state plasma concentrations of nortriptyline in psychiatric patients undergoing treatment with the drug (Hammer, Idestrom, and Sjoqvist, 1967) . Some patients have been found to have exceptionally high plasma levels forming a mode which was separated from the great majority (Sj6qvist et al, 1968) . Nortriptyline (NT) steady-state plasma levels have been shown to be under genetic control (Alexanderson, Price Evans, and in a study of identical and fraternal twins receiving a small daily dose of the drug. The study of Alexanderson et al (1969) did not appear, however, to contain persons who developed exceptionally high steady-state plasma levels.
Nortriptyline is easily absorbed from the intestine , individual differences in the binding of plasma protein are negligible (Borga et al, 1969) , and the renal excretion of unchanged nortriptyline accounts for less than 500 of the daily dose under steady-state conditions (Sjoqvist et al, 1968) . The variability in steady-state plasma concentration is therefore presumably due to differences in rate of metabolism and apparent volume of distribution (Alexanderson et al, 1969) . Investigations in human volunteers suggest that rate of metabolism is the quantitatively most important source of variance (B. Alexanderson and 0. Borga, unpublished observations).
The objects of the present study were to attempt to ascertain whether patients achieving very high steady-state NT plasma concentrations do so because of their genetic constitution and whether the manner of genetic control was monogenic or polygenic.
Material and Methods
High Nortriptyline Plasma Level Propositi. Three 'high-level' patient propositi had been ascertained. Two of these (L.S. and H.I.) were retested for plasma NT concentration using the technique described below. The third proposita (L.I.) was not available for retesting. The findings in the propositi are summarized in Table I (1968) . Dosage of Nortriptyline and the Taking of Blood Specimens. All subjects were given NT as sugar coated commercial tablets (Sensaval, Pharmacia). The dose was 25 mg three times daily for all subjects and was given for up to 8 days.
Blood specimens were generally taken on days 4, 5, 6, and 8, but sometimes they had to be drawn on different days. Three subjects (one relative and two random subjects) stopped taking the drug within three days due to side effects. Two subjects (one relative and one random subject) who had side effects were unable to continue the drug after day 6.
Clotting of the blood specimens was prevented with heparin and 05 ml 0-1-N hydrochloric acid was added to each 2-0 ml of plasma as a preservative. The specimens were stored at -20°C until determinations of plasma NT concentrations were performed, which generally occurred within 2 weeks.
Determination of Plasma Nortriptyline Concentrations. Plasma concentrations of NT were determined by the method described by Hammer and Barbiturates are known to influence the steady-state plasma levels of tricyclic antidepressants , and studies in progress by von Bahr et al (unpublished data from this laboratory) indicate that contraceptive steroids affect the kinetics of other drugs, such as antipyrine.
All other 40 subjects were free of significant disease and had not been exposed to drugs or other chemicals during at least 3 months before the study.
Specific enquiries were made concerning all doctor's prescriptions, patent medicines, laxatives, vitamins, tonics, and contraceptive steroids.
The Use of Plasma Concentrations to Characterize an Individual. Two measurements were utilized. First, the plasma NT concentrations on the sixth day; these were available for all subjects. Second, the area under the curve described by plotting NT concentrations (y) against days of NT therapy (x). The advantage of the latter procedure was that it utilized all observations available. One subject (Table II, case 3) could not be used for this procedure because of the paucity of the data available. A difficulty which arose with some subjects was the absence of a plasma NT concentration result on the eighth day, and this was resolved as follows. When the plasma NT concentration appeared to be approaching steady state on day 6, the mean of the values of days 4, 5, and 6 was used as the value for day 8. When the plasma NT concentration appeared to be increasing on day 6, This observation in itself suggested that a polymorphism (ie, variability controlled mainly by alleles at a single locus) was not present. Hence a polygenic control of the measurement under discussion seemed more likely. (Hurwitz, 1969) . This increased susceptibility of the elderly to adverse effects could theoretically be due to a diminished capacity to eliminate or metabolize drugs or to increased susceptibility of 'receptors'. The present work gives no evidence of major alterations in the kinetics of NT with increasing age.
Association of Side Effects with Plasma Concentration of Nortriptyline. The healthy relatives and random subjects tested in this study were given an explanation of the possible adverse effects of NT when their cooperation was obtained before starting drug therapy. During drug therapy and random subjects (Asberg et al, 1970) .
The Nature of the Genetic Control of Nortriptyline Plasma Concentrations. There are two main explanations to be considered. (1) That NT plasma levels are controlled as a polymorphism with 'high-level' propositi being genetically constituted as rare recessives, and (2) that NT plasma levels are controlled by a polygenic system with 'high-level' propositi being selected from the high end of the distribution curve of the population.
In favour of the first explanation was the finding of a separate mode of high-level propositi in the histogram of Sjoqvist et al (1968) . It must be realized, however, that this distribution is skewed and had not been normalized by log1o transformation. In addition, the analysis of the data is complicated by the fact that the subjects under study were patients and had received various types of psychotropic drugs, including barbiturates, before the study.
In (1969) in non-drug treated fraternal twins indicate considerable intrapair differences in only 4 out of the 11 twinships studied. This might hint that the number of genes involved in the control of NT plasma concentrations is small. Summary Twenty-nine relatives of 3 patient propositi developing extremely high plasma concentrations of nortriptyline and 20 random subjects were given 25 mg nortriptyline orally three times daily during 8 days. Plasma concentrations of nortriptyline were determined on days 4, 5, 6, and 8. Forty of the subjects were healthy and had not been exposed to drugs or chemicals 3 months before the study. Of the remaining 9 subjects, 5 were excluded from all further calculations because they had received barbiturates or contraceptive steroids.
Two measurements were used to characterize individuals: (1) plasma concentration of nortriptyline on the sixth day of treatment and (2) the area under the curve obtained by plotting nortriptyline concentrations (y) against days of treatment (x). The distributions of both were skewed but could be rendered approximately normal by log1o transformation. There was a significant regression of both on body weight, hence all values were adjusted to a standard body weight. There was no correlation between weight-adjusted values and age, nor any difference between males and females. There was a significant association between the occurrence of side effects and a plasma concentration above the population median.
There was no tendency towards bimodality in the distributions of all subjects, all relatives or all full siblings of high-level propositi on either of the measurements. The variances were larger in relatives of high-level propositi than in random subjects, and the mean of estimate (2) was larger in the relatives than in the random subjects.
Spouses and offspring of the full sibs of one of the propositi were tested. While the values of the full sibs on both measurements were at the upper tail of the distribution of the random subjects, the spouses were in the centre of the distribution. In the offspring of the full sibs, the variance of measurement (1) and the mean of measurement (2) were larger than in the random subjects.
It is concluded that the manner of inheritance of nortriptyline kinetics is likely to be polygenic.
